CDK2 and lung cancer: Intriguingly, RNA-Seq of polyploid (4N) versus diploid (2N) lung cancer cells revealed specific clusters of expressed genes that could account for the survival and persistence of polyploid cancer cells, despite ongoing CDK2 antagonism.